BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17088433)

  • 1. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
    Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
    J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
    Day YJ; Marshall MA; Huang L; McDuffie MJ; Okusa MD; Linden J
    Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G285-93. PubMed ID: 14715520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury.
    Day YJ; Li Y; Rieger JM; Ramos SI; Okusa MD; Linden J
    J Immunol; 2005 Apr; 174(8):5040-6. PubMed ID: 15814735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
    Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
    Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
    Arrenberg P; Maricic I; Kumar V
    Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation.
    Trobonjaca Z; Kröger A; Stober D; Leithäuser F; Möller P; Hauser H; Schirmbeck R; Reimann J
    J Immunol; 2002 Apr; 168(8):3763-70. PubMed ID: 11937527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma.
    Day YJ; Huang L; Ye H; Li L; Linden J; Okusa MD
    J Immunol; 2006 Mar; 176(5):3108-14. PubMed ID: 16493070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.
    Ajuebor MN; Aspinall AI; Zhou F; Le T; Yang Y; Urbanski SJ; Sidobre S; Kronenberg M; Hogaboam CM; Swain MG
    J Immunol; 2005 Jun; 174(12):8027-37. PubMed ID: 15944310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
    Maeda M; Shadeo A; MacFadyen AM; Takei F
    J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
    Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A
    J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.
    Lappas CM; Rieger JM; Linden J
    J Immunol; 2005 Jan; 174(2):1073-80. PubMed ID: 15634932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity.
    Oh K; Kim S; Park SH; Gu H; Roopenian D; Chung DH; Kim YS; Lee DS
    J Immunol; 2005 Feb; 174(4):2030-6. PubMed ID: 15699132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes.
    Yang Z; Day YJ; Toufektsian MC; Xu Y; Ramos SI; Marshall MA; French BA; Linden J
    Circulation; 2006 Nov; 114(19):2056-64. PubMed ID: 17060376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells.
    Li Y; Oskouian RJ; Day YJ; Rieger JM; Liu L; Kern JA; Linden J
    Neuroscience; 2006 Sep; 141(4):2029-39. PubMed ID: 16777350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury.
    Li L; Huang L; Sung SS; Lobo PI; Brown MG; Gregg RK; Engelhard VH; Okusa MD
    J Immunol; 2007 May; 178(9):5899-911. PubMed ID: 17442974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.
    Ragin MJ; Sahu N; August A
    Infect Immun; 2006 Jan; 74(1):282-8. PubMed ID: 16368982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.
    Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells.
    Pellicci DG; Hammond KJ; Coquet J; Kyparissoudis K; Brooks AG; Kedzierska K; Keating R; Turner S; Berzins S; Smyth MJ; Godfrey DI
    J Immunol; 2005 Oct; 175(7):4416-25. PubMed ID: 16177083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.